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Abstract
Introduction: Contrast-enhanced ultrasound (CEUS) is a new technique that might enable portable and non-
invasive organ perfusion quantification at the bedside. However, it has not yet been tested in critically ill patients.
We sought to establish CEUS’s feasibility, safety, reproducibility and potential diagnostic value in the assessment of
renal cortical perfusion in the peri-operative period in cardiac surgery patients.
Methods: We recruited twelve patients deemed at risk of acute kidney injury (AKI) planned for elective cardiac
surgery. We performed renal CEUS with destruction-replenishment sequences before the operation, on ICU arrival
and the day following the admission. Enhancement was obtained with Sonovue® (Bracco, Milano, Italy) at an
infusion rate of 1 ml/min. We collected hemodynamic parameters before, during and after contrast agent infusion.
At each study time, we obtained five video sequences, which were analysed using dedicated software by two
independent radiologists blinded to patient and time. The main output was a perfusion index (PI), corresponding
to the ratio of relative blood volume (RBV) over mean transit time (mTT).
Results: All 36 renal CEUS studies, including 24 in the immediate post-operative period could be performed and
were well tolerated. Correlation between readers for PI was excellent (R2 = 0.96, P < 0.0001). Compared with
baseline, there was no overall difference in median PI’s on ICU admission. However, the day after surgery, median
PI’s had decreased by 50% (P < 0.01) (22% decrease in RBV (P = 0.09); 48% increase in mTT (P = 0.04), both
suggestive of decreased perfusion). These differences persisted after correction for haemoglobin; vasopressors use
and mean arterial pressure. Four patients developed AKI in the post-operative period.
Conclusions: CEUS appears feasible and well-tolerated in patients undergoing cardiac surgery even immediately
after ICU admission. CEUS derived-parameters suggest a decrease in renal perfusion occurring within 24 hours of
surgery.
Keywords: Renal perfusion, microcirculation, contrast-enhanced ultrasonography, cardiac surgery, peri-operative
period
Introduction
Acute kidney injury (AKI) is a frequent complication of
cardiac surgery and renal replacement therapy (RRT) is
required in 1 to 4% of the cases [1-6]. Such severe AKI
has been shown to be independently associated with
increased in-hospital mortality [7].
The pathophysiology of cardiac surgery-associated AKI
is still poorly understood. A decrease in renal blood flow
(RBF) is believed to play a pivotal role in its pathogenesis
[8,9]. There are, however, only very limited human data
supporting this concept. Indeed, RBF [10] measurement,
irrespective of the technique used, has only been reported
in 46 critically ill patients (five studies) within the last sixty
years. Thus, our knowledge, understanding, and theoreti-
cal constructs regarding renal perfusion in critically ill
patients are based on extremely weak direct evidence.
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Furthermore, given the complex and heterogeneous
nature of the renal vasculature, some pathophysiological
processes might be associated with increased global RBF
[11,12] despite loss of function suggesting intra-renal
shunting [13]. Therefore, techniques allowing the study
of microcirculatory parameters might be more valuable
in increasing our understanding of the pathophysiology
of AKI. Such parameters can be evaluated by a relatively
recent imaging technique, renal contrast-enhanced ultra-
sonography (CEUS). However, CEUS is still used infre-
quently in clinical practice. In particular, there are no
data on the feasibility, safety, reproducibility and diag-
nostic value of CEUS in critically ill patients. We
hypothesized that CEUS would be safe and feasible and
allow quantification of changes in the renal cortical
microcirculation in patients undergoing cardiac surgery.
Methods
The study was approved by the Austin Health Research
Ethics Committee (H2010/03798).
Study protocol
We approached 12 patients planned for elective cardiac
surgery and obtained informed consent. We restricted
inclusion to patients deemed at high risk of AKI [14,15].
We therefore included only patients fulfilling one or
more of the following criteria: age above 70 years, pre-
existing renal impairment (pre-operative plasma creati-
nine concentration >120 μmol/l), New York Heart
Association (NYHA) class III/IV or impaired left ventri-
cular function defined as left ventricular ejection frac-
tion (LVEF) <35%, valvular surgery, redo cardiac surgery
or insulin-dependent type 2 diabetes mellitus.
We excluded patients with intolerance to Sonovue®
(Bracco, Milano, Italy) or any other ultrasound contrast
agent, end stage renal disease (plasma creatinine concen-
tration >300 μmol/l or on haemodialysis, emergency car-
diac surgery, planned off-pump cardiac surgery, known
blood-borne infectious diseases, inability to obtain
informed consent or enrolment in a conflicting research
study. For each study patient, we performed renal CEUS
on three occasions: before the surgical procedure (base-
line), on ICU admission and the day after the operation.
Ultrasound equipment and settings
We performed all measurements using an IU22® ultra-
sound system (Philips, Amsterdam, Netherlands) with a
C5-1 probe (1 to 5 MHz). We used contrast-specific
mode with a low mechanical index (MI: 0.06) (R1). We
set gain and depth for each patient during baseline and
kept them constant for all further measurements.
We used Sonovue® as the contrast agent. The agent was
administered as continuous infusion at a rate of 1 ml/min
using a VueJect™ syringe pump (Bracco Research, Geneva,
Switzerland). After the start of the infusion, we allowed a
2-minute equilibration period and then performed and
recorded five destruction-reperfusion sequences. We
achieved contrast microbubble destruction by applying five
pulses at high MI (flash: MI 1.24) and observed refilling at
low MI (15 seconds total refilling time). We ascertained
full destruction of contrast agent in the scan plane before
performing destruction-reperfusion sequences.
For further examinations, to ensure that a similar por-
tion of the renal cortex was examined, we used anatomi-
cal landmarks and visually compared the image with
previously acquired sequences.
Data analyses
We exported destruction-reperfusion sequences in digi-
tal imaging and communication in medicine (DICOM)
format and analysed them using dedicated software
(Sonotumor™, Bracco Research, Geneva, Switzerland).
These analyses were performed by two independent
radiologists (MG and TS) blinded to patient and time.
In order to compensate for minor breathing artefacts, all
sequences were applied with motion compensation prior
to the start of the analyses.
For each sequence, one region of interest (ROI) was
drawn. In order to minimize the influence of local per-
fusion heterogeneities, this ROI was drawn so that it
enclosed all visible renal cortex on the surface of the
kidney closest to the ultrasound probe. Cortex that was
only intermittently visible because of breathing or other
artefacts was not included in the ROI.
The software generates a perfusion index (PI), which
is thought to be proportional to perfusion within an
ROI. Such a PI is calculated by dividing the relative
blood volume (RBV) by the mean transit time (mTT)
and is expressed in arbitrary units (a.u.). These para-
meters have been described in detail elsewhere [16,17].
In brief, the RBV is a measure of pixel luminance and is
proportional to contrast agent concentration within an
ROI (it increases with higher levels of perfusion). The
mTT is a measure of the time to replenishment after
flash destruction of the contrast agent (it decreases with
higher levels of perfusion).
For each patient and study time, the median value for
the five measurements was considered for analysis. Sub-
optimal sequences with inadequate insonification or
excessive breathing artefact were excluded as evaluated
by both readers. In case of disagreement on sequence
exclusion, the two readers reviewed the sequences
simultaneously and consensus was reached.
Safety parameters
For baseline studies we performed non-invasive haemo-
dynamic (cardiac rhythm, non-invasive blood pressure
and pulse oximetry) monitoring during contrast-agent
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infusion and for the subsequent 30 minutes. For post-
operative studies full haemodynamic monitoring includ-
ing invasive arterial blood pressure, pulmonary artery
pressures, and cardiac index (via pulmonary artery
catheter) was available for all patients.
Statistical analysis
Analysis was performed using SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA). All outcomes were
assessed for normality and as RBV, mTT and PI were
all well-approximated by log-normal distributions, each
was log-transformed prior to analysis. Inter-observer
agreement was determined using correlation analyses as
well as intra-class correlation [18]. For both tests, values
ranged from 0 to 1 (0: absence of correlation, 1: perfect
correlation). They were reported using a Bland-Altman
plot with 95% limits of agreement.
Descriptive results are reported as mean (SD) for nor-
mally distributed data, otherwise as median (IQR). Longi-
tudinal analysis determining changes from baseline was
performed using mixed linear modelling with each patient
treated as a random effect. Multivariable models were con-
structed considering all available haemodynamic and bio-
logical parameters (mean arterial pressure, cardiac index,
vasoconstrictor infusion, lactate serum level, arterial pH,
and serum haemoglobin level) with statistically significant
variables included in the final models. A two-sided P-value
of 0.05 was considered to be statistically significant.
Results
Patients’ description and outcomes
Characteristics of the twelve patients are presented in
Table 1. The procedure was coronary artery graft
surgery (CAGS) in six patients, valvular replacement
surgery (including double-valve surgery) in three and a
combination of CAGS and valvular surgery in three
patients. Median length of stay in hospital was 11 (8.0
to 16.5) days. All patients survived to hospital discharge.
Feasibility
Although some of the scans were performed on haemo-
dynamically unstable patients, all of them could be per-
formed as per protocol. As an example, the scan on
ICU admission was completed at a mean of 110 (SD 42)
minutes after ICU admission. All scans were performed
in less than half an hour (effective infusion time <8 min-
utes for all patients).
Because of increased subcutaneous fluid and drains
after the operation, adequate visualisation of the kidney
was sometimes challenging. However, adequate contrast
enhancement with contrast agent was obtained for all
patients at all time points. At least one sequence for
each study time point was judged by the two readers to
be of adequate quality for interpretation. An illustration
of destruction-refilling sequences obtained during the
study is presented in Figure 1.
Tolerance
Overall, 36 contrast-enhanced ultrasound examinations
were performed using a total of 72 vials of Sonovue®
(10 ml per scan). Of these, twenty-four were performed
in the ICU, including nine examinations in patients
requiring vasoconstrictors for severe hypotension. No
adverse effect was noted. Haemodynamic characteristics
of patients before and after CEUS are presented in
Table 2.















1 123 CABG 79 >60% 48 N Y 142 I 8
2 101 CABG 104 >60% 36 Y N 87 0 7
3 107 AVR + CABG 207 40% 45 Y N 152 R 7
4 80 MVR 130 >60% 38 Y N 98 0 32
5 76 AVR + CABG 226 20% 68 Y Y 47 R 62
6 83 MVR + TVR 119 >60% 59 Y Y 47 0 8
7 81 CABG 86 >60% 40 N N 59 0 8
8 78 AVR 114 40% 32 N N 120 0 15
9 81 CABG 69 40% 71 Y N 59 0 15
10 78 CABG No CPB >60% 54 N N 113 0 11
11 79 CABG 90 >60% 56 Y N 52 0 11
12 106 AVR + CABG 151 >60% 74 Y Y 86 R 18
aCalculated with the Cockroft-Gault equation. CPB, cardiopulmonary bypass; CABG, coronary arteries bypass graft; AVR, aortic valve replacement; MVR, mitral
valve replacement; TVR, tricuspid valve replacement; LVEF, left ventricular ejection fraction; APACHE, Acute Physiology and Chronic Health Evaluation; RIFLE: risk,
injury, failure, loss and end-stage renal failure; VasoC, vasoconstrictors (Y, yes; N, no); GFR, glomerular filtration rate.
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Inter-observer agreement
Correlation between readers was excellent for PI (R2 =
0.96, P < 0.0001) and for RBV (R2 = 0.94, P < 0.001) but
only moderate for mTT (0.51, P < 0.0001). Intra-class
correlation was 0.69 (95% CI 0.5, 0.84) for PI, 0.68
(95% CI 0.48, 0.83) for RBV and 0.43 (95% CI 0.25,
0.63) for mTT.
As presented in Figure 2, agreement between readers
was good. Mean bias for PI was -412 a.u. (6.9% of the
mean value) with limits of agreement from -4,065 to
3,243 a.u. (± 61% of the mean value). For RBV, the
mean bias was -1,320 (9.2% of the mean value) with lim-
its of agreements from -5,670 to 3,030 (± 30.4% of the
mean value). Similarly, for mTT the mean bias was
Figure 1 Illustration of destruction-reperfusion sequence. During continuous infusion of the contrast agent, microbubble destruction is
obtained by applying pulses at high mechanical index (high ultrasound intensity). Microcirculation replenishment is then observed. All images
represent renal contrast-enhanced ultrasonography (CEUS), the left part of the image shows contrast-image mode imaging and the right part
the standard (B-mode) image. (a) Immediately after the flash; (b) during replenishment (2 seconds after the flash); (c) at full replenishment (6
seconds after the flash); (d) sequence analysis with Sonotumor®: a region of interest was drawn (yellow line) in the largest possible area of renal
cortex closer to the ultrasound probe. The software generates a time intensity curve. This curve is used to generate CEUS-derived parameters.
Table 2 Safety data
Measurement Two hours pre One hour pre CEUS One hour post Two hours post P-value
Cardiac index 2.87 (0.62) 2.96 (0.46) 2.9 (0.45) 2.9 (0.58) 2.92 (0.48) 0.99
Heart rate, beats per minute 84.67 (15.56) 83.83 (15.01) 84 (12.48) 84.65 (14.62) 84.88 (15.08) 0.69
Lactate, mmol/l 1.73 (1.05) 1.56 (0.84) 1.43 (0.85) 1.81 (0.87) 1.62 (1.09) 0.72
Mean arterial pressure, mmHg 80.17 (15.24) 79.96 (10.14) 78.46 (9.62) 77.17 (11.24) 76.42 (10.4) 0.43
Systolic pulmonary arterial pressure, mmHg 29.28 (15.13) 28.8 (14.17) 27.85 (14.12) 28.67 (14.74) 28.71 (15.47) 0.98
Noradrenaline infusion rate, mcg/min 1.75 (2.83) 1.88 (2.83) 1.92 (3.59) 2.5 (4.6) 2.42 (4.6) 0.94
Respiratory rate, breath per minute 15.26 (4.69) 14.96 (4.65) 16.04 (4.54) 14.83 (3.75) 15.14 (3.87) 0.39
Data are presented as mean (SD). CEUS, contrast-enhanced ultrasound.
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-0.39 (9.1% of the mean value) with limits of agreements
-7.8 to 7.1 (± 172% of the mean value).
CEUS-derived parameters
Perfusion indices (PI)
Baseline PI values ranged from 1,069 to 29,446 a.u.
Changes in such values indexed to baseline are presented
in Figure 3. Compared with baseline, PI values decreased
24 hours after admission in nine patients. Pooled values
for PI are presented in Figure 4. PI decreased from a base-
line median value of 6,750 (2,042 to 8,263) to 3,936 (1,645
to 6,004) on ICU admission (-42%, P = 0.33) and to 3,308
(1,243 to 4,573) 24 hours later (-51%, P < 0.01). After
adjustment for mean arterial pressure, inotrope infusion
and haemoglobin, there was no difference in PI between
baseline and ICU admission (P = 0.70) but there was a sig-
nificant decrease in PI 24 hours after admission (P = 0.03).
Relative blood volume (RBV)
Baseline RBV values ranged from 4,846 to 29,958 a.u.
Compared with baseline, nine patients had lower RBV
24 hours after surgery. Pooled RBV decreased from
15,342 a.u. (IQR 7,862 to 20,490) on baseline to 13,113
Figure 2 Bland-Altman plot for inter-observer agreement (perfusion indices). a.u., arbitrary units.
Figure 3 Perfusion indices: individual patients results indexed.
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a.u. (IQR 8,952 to 17,310) on ICU admission (-14%, p =
0.31) and to 11929 a.u. (IQR 6,312 to 15,904) 24 hours
after admission (-22%, P = 0.09). After adjustment for
mean arterial pressure, inotrope infusion and haemoglo-
bin, there was no difference in RBV between baseline
and ICU admission (P = 0.29) and a trend for a decrease
24 hours after admission (P = 0.11).
Mean transit time (mTT)
Baseline mTT values ranged from 1.0 to 7.7 seconds. Com-
pared with baseline, most (10/12) patients experienced an
increase in their mTT 24 hours after the admission.
Pooled mTT increased from a median value of 2.9
seconds (IQR 2.1 to 3.3) on baseline to 3.3 (IQR 2.0 to
4.2) on ICU admission (+14%, P = 0.73) and to 4.3 (IQR
2.8 to 4.7) 24 hours later (+48%, P = 0.04). After adjust-
ment for mean arterial pressure, inotrope infusion and
haemoglobin, there was no difference in mTT between
baseline and ICU admission (P = 0.15) or 24 hours after
admission (P = 0.37).
Correlation with changes in creatinine levels
Four patients developed AKI (risk, injury, failure, loss,
end-stage renal failure (RIFLE)-R in three and RIFLE-I in
one patient) but none required RRT. There was no corre-
lation between changes in PI in the first 24 hours after
cardiac surgery and changes in serum creatinine levels.
Discussion
Key findings
Using CEUS we were able to quantify changes in the
microcirculation of the renal cortex before and after
cardiac surgery in 12 patients deemed at risk of AKI. In
these patients we performed 36 CEUS scans, including
24 in the ICU. Such studies were all performed in less
than half an hour and did not interfere with clinical
management. Tolerance was excellent and no adverse
effect was noted. When compared with baseline, we
found no overall difference in CEUS-derived parameters
(PI, RBV and mTT) on ICU admission. However, 24
hours after the operation, there was an overall 50%
decrease in the PI, suggestive of decreased renal cortical
perfusion.
Comparison with previous studies
The general safety of CEUS has been demonstrated in
several large retrospective studies [19-21], one of which
included critically ill patients [21]. The reported rates of
adverse events, including potentially severe anaphylac-
toid reactions or complement activation-related pseudo-
allergy (CARPA) [22], are in the range of 1 per 10,000
administrations. There are, however, no detailed data on
CEUS safety after cardiopulmonary bypass, or during
mechanical ventilation or vasoconstrictor administration.
Our study provides such information. In addition, we
were able to report the absence of changes in systolic
pulmonary pressure after contrast-agent administration.
This is consistent with previous findings [23] in patients
undergoing right heart catheterization with Definity® as
a contrast agent. Our data confirm the absence of mea-
surable physiological changes even in haemodynamically
unstable patients during administration of Sonovue® for
CEUS.
In a previous study [24], we evaluated the ability of
CEUS to detect changes in renal cortical perfusion in
healthy volunteers. We found that CEUS was able to
detect a 15% change in renal flow as induced by angio-
tensin II or captopril administration. These results were
consistent with those found by Kishimoto et al. [25]
using a different technique. However, to the best of our
knowledge, there has not been any previous attempt to
use CEUS for quantification of renal perfusion in
patients undergoing cardiac surgery, hence our findings
are novel and cannot be compared with previous data.
Estimates of global renal blood flow have been obtained
with the measurement of para-immuno hippurate clear-
ance corrected by renal vein sampling [26]. This techni-
que requires the insertion of an 8-Fr catheter into the
left renal vein under fluoroscopic guidance. Using this
invasive strategy, authors have demonstrated, in similar
patients, the potential of noradrenaline to improve oxy-
gen delivery, glomerular filtration rate (GFR) and the
renal oxygen supply/demand relationship in cardiac sur-
gery patients with vasodilatory shock and AKI [27], as
well as an increase in RBF induced by mannitol [28] or
dopamine [29]. The lack of correlation between estimate
Figure 4 Overall results for perfusion indices.
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of flow and function is consistent with data obtained
with cine-phase contrast magnetic resonance imaging
(MRI) [30].
Clinical significance
Our pilot study supports the feasibility and safety of
CEUS at the bedside in the ICU, in particular in the
period around cardiac surgery, even in patients deemed
at risk of AKI. Despite some relative haemodynamic
instability, adequate visualisation of the kidney was feasi-
ble in all cases. The finding of decreased cortical perfu-
sion at 24 hours is plausible and consistent with
previous findings [30]. This study, together with larger
safety studies, establishes CEUS as a fast, safe and feasi-
ble procedure in critically ill patients. Larger studies are
required to confirm or refute the decrease in renal corti-
cal perfusion after cardiac surgery suggested by our
results.
Strength and limitations
To the best of our knowledge, this study is the first to
report non-invasive, real-time measurement of renal
cortical microcirculation in humans before and after
cardiac surgery. In addition, it has several strengths.
Extensive invasive monitoring was available for all
patients in the post-operative period, enabling detection
of subclinical adverse events. All scans were performed
by a single operator (AS) and were analysed by two
senior radiologists blinded to patient and time. This
enabled evaluation of inter-observer agreement. Despite
important baseline heterogeneity, a statistically signifi-
cant decrease in renal cortical perfusion was detected
with a sample size as small as 12 patients.
On the other hand, this study has several limitations.
First, CEUS parameters could not be correlated to a com-
parator/gold standard. Indeed, such measurements of the
microcirculation are novel and no gold standard has
emerged. Comparison with macrocirculation using tech-
niques such as PAH clearance or MRI would have been
theoretically possible but logistically very complicated or
invasive and could not occur simultaneously. In addition,
such comparison would be informative at best, but could
also potentially be misleading, as the correlation between
macro- and microcirculation is not necessarily linear.
There was important heterogeneity in individual
results and baseline perfusion indices. However, such
heterogeneity was not likely to arise from interpretation
errors, as illustrated by the good agreement between the
readers. Similar heterogeneity in baseline measurements
was found in our previous study in healthy subjects
[24]. It is more likely to be associated with different
patient properties, such as depth of organ, thickness of
subcutaneous tissue and the renal capsule or other
properties influencing ultrasound beam attenuation.
This is consistent with the greater variability observed
in the RBV component, which is more sensitive to
attenuation (as it is a measure of the intensity of the
ultrasound signal). The mTT component, which is the
time to replenishment, could be a more robust measure.
However, this heterogeneity should not have influenced
the validity of our results, as only changes in values
from baseline in identical patients were considered.
Decreased renal perfusion was not found in all patients.
However, patients had different clinical courses and het-
erogeneity would be expected, given the differences in
age, type of operation and duration of bypass.
We did not find a correlation between CEUS indices
and impairment of renal function; however, given the
small number of patients, this needs to be confirmed in
larger studies. Finally, we were not able to report on
medullary perfusion. Indeed, such a parameter together
with cortico-medullary perfusion ratios of CEUS para-
meters would be of great interest. However, medullary
perfusion was not measurable with adequate reproduci-
bility using our current technology.
Future studies
Further studies are required to confirm or refute these
results. In particular, due to the limited number of
patients included in this study, we were not able to
draw any conclusion about correlation of changes in
CEUS-derived indices and clinical outcomes such as
AKI, need for RRT or mortality.
Conclusions
CEUS is feasible and well-tolerated in patients under-
going cardiac surgery, in particular immediately after
ICU admission. CEUS-derived parameters suggest a
decrease in renal perfusion occurring within 24 hours of
surgery. Further studies with larger sample size are
required to establish whether there is a correlation
between changes in microvascular cortical flow and
markers of renal function.
Key messages
• CEUS is safe and feasible in critically ill patients
and in particular during the cardiac surgery peri-
operative period.
• In patients at risk of AKI, CEUS-derived para-
meters suggest a decrease in renal cortical perfusion
in the 24 hours following cardiac surgery.
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